Page 358 - TBE_Book_V2_2019
P. 358

Chapter 12b: TBE in Norway


          Table 2: TBE reporting and vaccine prevention in Norway

                              Hospitals and General Practitioners
                              Only cases with meningitis/encephalitis are notifiable.

                              Criteria:
          Mandatory TBE         Detection of specific antibody response in serum and/or cerebrospinal
          reporting             fluid
                              and/or
                                Detection of TBEV in cerebrospinal fluid and/or serum by isolation and
                                nucleic acid analysis
                              (Source: www.fhi.no)
          Other TBE           Ongoing studies: BorrSci (ID 2015113/243737), TickVA (ID 2014107) and the
          surveillance        Barents region project (ID B1710)
                              No. TBE has been a mandatory notifiable disease to MSIS (Norwegian
          Special clinical
          features            Surveillance System for Communicable Diseases) since 1975.
                              (Source: https://www.fhi.no)
                              TicoVac, Pfizer

                              TicoVac Junior, Pfizer

          Available vaccines   Since the area specific TBE vaccine recommendations were implemented in
                              Norway in 2009, on average 17,424 doses of TBE-vaccine were distributed
                              annually (2009-2018). On average, 23% have been pediatric doses.

                              (Source: Norwegian Institute of Public Health’s Warehouse Management System)
                              People who spend a lot of time outdoors in areas with a known risk of TBE
          Vaccination         infection (Table 1) should consider TBE vaccination. This recommendation
          recommendations and  applies especially to people who often get tick bites such as forestry
          reimbursement       workers, orienteers, and others who spend much time outdoors. There is no
                              reimbursement in place. (Source: https://www.fhi.no)

                              In Norway, all immunizations should be registered into the national
                              immunization register, SYSVAK. According to SYSVAK, almost 19,000 persons
                              have received at least 3 doses of TBE vaccine. There is no information about
                              risk factors in the register.
          Vaccine uptake
                              For vaccines outside the childhood immunization program, registration into
          by age group/risk
          group/general       SYSVAK is consensual. The number of doses actually given therefore could
          population          be higher than the numbers registered, and this is probably the case for TBE
                              vaccine, as the number of doses distributed is higher than the number of
                              doses entered into the register.

                              [Source: Norwegian Immunization Registry (SYSVAK) and Norwegian Institute of
                              Public Health’s Warehouse Management System]

          Name, address/
                              Norwegian Institute of Public Health. (Source: https://www.fhi.no)
          website of TBE NRC


                                                  353
   353   354   355   356   357   358   359   360   361   362   363